Detail page

Knowledge Web

Person

Peter Riederer (1942-)

Arzt

Name	Peter Riederer
Time	1942- (Date of birth and death)
Place	Königsberg (Geburtsort) Österreich Deutschland
Gender	männlich
Academic degree	Univ.Doz., Univ.Prof., Dipl.-Ing., Dr.techn.
Profession	Arzt (characteristic profession) Neurologe Neurochemiker Psychiater
Variant	P. Riederer Peter F. Riederer Peter Franz Riederer (vollständiger Name)
Related	Deutsche Akademie der Naturforscher Leopoldina (Mitglied, Matrikelnummer 07166) (2007-) techn. Chemie (Studienfach)
Source	LCAuth
Record type	Person
GND-Identifier	131817833
Record ID	131817833
Involved in show all Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease 45 years German Society of Biological Psychiatry (DGBP) Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice Perspective: Treatment for disease modification in chronic neurodegeneration α-Synuclein in Parkinson’s disease: causal or bystander? Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects Classification of advanced stages of Parkinson’s disease: translation into stratified treatments Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson’s disease Cognitive impairment in 873 patients with idiopathic Parkinson’s disease : Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD) Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson : Untersuchung an 1449 Patienten im ambulanten Versorgungssektor in Deutschland Depression and care-dependency in Parkinson’s disease: Results from a nationwide study of 1449 outpatients Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch Grundlagen der Neuro-Psychopharmakologie : Ein Therapiehandbuch Therapeutische Ansätze zur neurodegenerativen Protektion Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie Diagnostic staging of Parkinson’s disease: conceptual aspects Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie 4. Drei-Länder-Symposium für Biologische Psychiatrie : Würzburg, 10. - 12. Oktober 1996 Neuro-Psychopharmaka : Ein Therapie-Handbuch Band 5: Parkinsonmittel und Nootropika The role of brain dopamine The Role of Brain Dopamine Understanding the neurotransmitters : key to the workings of the brain Depression : Biochemie, Klinik, Therapie Morbus Parkinson : Selegilin (R-(-)-Deprenyl) ; Movergan ; e. neues Therapiekonzept MAO-B-inhibitor selegiline (R-(-)-Deprenyl) : a new therapeut. concept in the treatment of Parkinson's disease ; proceedings of the internat. symposium in Berlin, January 23 - 25, 1987 Neurotransmitter und menschliches Verhalten Neurotransmitter und menschliches Verhalten Die Parkinson-Krankheit : Biochemie, Klinik, Therapie L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft L-Dopa-Substitution der Parkinson-Krankheit : Geschichte — Gegenwart — Zukunft Biogene Transmitter und Akupunktur Parkinson's disease : biochemistry, clinical pathology, and treatment Parkinson’s Disease : Biochemistry, Clinical Pathology, and Treatment Die Parkinson-Krankheit : Biochemie, Klinik, Therapie Neuro-Psychopharmaka : ein Therapie-Handbuch Neurotransmitter und menschliches Verhalten

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Peter Riederer (1942-)

Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations

The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease

45 years German Society of Biological Psychiatry (DGBP)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Perspective: Treatment for disease modification in chronic neurodegeneration

α-Synuclein in Parkinson’s disease: causal or bystander?

Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments

Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson’s disease

Cognitive impairment in 873 patients with idiopathic Parkinson’s disease : Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD)

Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson : Untersuchung an 1449 Patienten im ambulanten Versorgungssektor in Deutschland

Depression and care-dependency in Parkinson’s disease: Results from a nationwide study of 1449 outpatients

Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch

Grundlagen der Neuro-Psychopharmakologie : Ein Therapiehandbuch

Therapeutische Ansätze zur neurodegenerativen Protektion

Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie

Diagnostic staging of Parkinson’s disease: conceptual aspects

Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie

Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie

Die Parkinson-Krankheit : Grundlagen, Klinik, Therapie

4. Drei-Länder-Symposium für Biologische Psychiatrie : Würzburg, 10. - 12. Oktober 1996

Neuro-Psychopharmaka : Ein Therapie-Handbuch Band 5: Parkinsonmittel und Nootropika

The role of brain dopamine

The Role of Brain Dopamine

Understanding the neurotransmitters : key to the workings of the brain

Depression : Biochemie, Klinik, Therapie

Morbus Parkinson : Selegilin (R-(-)-Deprenyl) ; Movergan ; e. neues Therapiekonzept

MAO-B-inhibitor selegiline (R-(-)-Deprenyl) : a new therapeut. concept in the treatment of Parkinson's disease ; proceedings of the internat. symposium in Berlin, January 23 - 25, 1987

Neurotransmitter und menschliches Verhalten

Neurotransmitter und menschliches Verhalten

Die Parkinson-Krankheit : Biochemie, Klinik, Therapie

L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft

L-Dopa-Substitution der Parkinson-Krankheit : Geschichte — Gegenwart — Zukunft

Biogene Transmitter und Akupunktur

Parkinson's disease : biochemistry, clinical pathology, and treatment

Parkinson’s Disease : Biochemistry, Clinical Pathology, and Treatment

Die Parkinson-Krankheit : Biochemie, Klinik, Therapie

Neuro-Psychopharmaka : ein Therapie-Handbuch

Neurotransmitter und menschliches Verhalten